Table 1.
Method | Average content in control | Advantages | Limitations | Ref. |
---|---|---|---|---|
Colorimetric methods | ||||
ACB | 0.39-0.43 ABSU 79 ± 6.3 U/mL |
Simple, low cost, automation possibility | Dependent on pH, temperature, level of HSA and free FA, the proportion of the intact HSA N-terminus, the state of cys34 oxidation in HSA, lack of standardization | [23, 29, 51, 52, 54] |
CAB | 0.53 ± 0.04 ABSU | Affordable and simple, small sample volume, the possibility to analyze the structural differences of HSA, independent of HSA concentration | Dependent on HSA and free FA concentrations, on the proportion of the intact N-terminus of HSA, lack of standardization | [53] |
NAB | 0.415 ± 0.084 ABSU | More sensitivity than ACB | Not widespread, not enough information | [48, 49] |
ACuB | There is no data | More accurate than ACB, highly reliable, and highly sensitive | Poorly developed not enough information | [50] |
| ||||
Immunochemical methods | ||||
ELISA | 45.7 ± 23.9 ng/mL 62.21 ± 21.47 ng/mL 43.4 ng/mL (1.1–320.3) |
High sensitivity and specificity for NTS | Cost analysis, high antibody affinity | [55] [56] [57] |
LCB | 50 μg/mL | Simple, does not require measuring technology | The high cost of the biosensor and the lack of its production, low sensitivity and accuracy | [58] |
SPRI | 10-100 ng/L | High sensitivity and specificity | Availability of appropriate equipment, no clinical trials | [59] |
Q-XRF | 0.05 U/mL | Availability of appropriate equipment, no clinical trials | [60, 61] |
Note: ACB: Albumin Cobalt Binding test; ACuB: Albumin Copper Binding assay; CAB: Cobalt-Albumin Binding test; ELISA: enzyme-linked immunosorbent assay; FA: fatty acids; LCB: liquid crystal biosensor; NAB: nickel-albumin binding assay; SPRI: surface plasmon resonance immunosensor; Q-XRF: X-ray fluorescence spectroscopy; ABSU: absorbance units; U/mL: units in liter (one unit was defined as of free Co2+ in the reaction mixture per mL of serum sample.